A novel function of eIF2α kinases as inducers of the phosphoinositide-3 kinase signaling pathway

Molecular Biology of the Cell

Volumn 18, Issue 9, 2007, Pages 3635-3644

  Kazemi, Shirin ^a   Mounir, Zineb ^a   Baltzis, Dionissios ^a   Raven, Jennifer F ^a   Wang, Shuo ^a   Krishnamoorthy, Jothi Latha ^a   Pluquet, Olivier ^a,c   Pelletier, Jerry ^b   Koromilas, Antonis E ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 2ALPHA; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SERINE; SMALL INTERFERING RNA; CARRIER PROTEIN; EIF4EBP1 PROTEIN, MOUSE; INITIATION FACTOR 2; PERK KINASE; PHOSPHOPROTEIN; PROTEIN KINASE R; S6 KINASE; UNCLASSIFIED DRUG;

ALPHA CHAIN; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; ENVIRONMENTAL STRESS; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; TRANSLATION INITIATION; TRANSLATION REGULATION; ANIMAL; BIOLOGICAL MODEL; CELL DEATH; ENZYME ACTIVATION; HUMAN; METABOLISM; PHOSPHORYLATION; PROTEIN SYNTHESIS; TUMOR CELL LINE;

EUKARYOTA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CARRIER PROTEINS; CELL DEATH; CELL LINE, TUMOR; EIF-2 KINASE; ENZYME ACTIVATION; EUKARYOTIC INITIATION FACTOR-2; HUMANS; MICE; MODELS, BIOLOGICAL; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION;

EID: 34548511321     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E07-01-0053     Document Type: Article

References (56)

1. Abraham, N. et al. (1999). Characterization of transgenic mice with targeted disruption of the catalytic domain of the double-stranded RNA-dependent protein kinase, PKR. J. Biol. Chem. 274, 5953-5962.
2. Abraham, R. T. (2004). PI 3-kinase related kinases: 'big' players in stress-induced signaling pathways. DNA Repair (Amst.) 3, 883-887.
3. Baltzis, D., Li, S., and Koromilas, A. E. (2002). Functional characterization of pkr gene products expressed in cells from mice with a targeted deletion of the N terminus or C terminus domain of PKR. J. Biol. Chem. 277, 38364-38372.
4. Beugnet, A., Tee, A. R., Taylor, P. M., and Proud, C. G. (2003). Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability. Biochem. J. 372, 555-566.
5. Boyce, M. et al. (2005). A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 307, 935-939.
6. Chan, T. O., Rodeck, U., Chan, A. M., Kimmelman, A. C., Rittenhouse, S. E., Panayotou, G., and Tsichlis, P. N. (2002). Small GTPases and tyrosine kinases coregulate a molecular switch in the phosphoinositide 3-kinase regulatory subunit. Cancer Cell 1, 181-191.
7. Chen, J. J. (2000). Heme-regulated EIF2alpha kinase. In: Translational Control of Gene Expression., ed. N. Sonenberg, J.W.B. Hershey, and M. B. Mathews, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 529-546.
8. Clemens, M. J. and Elia, A. (1997). The double-stranded RNA-dependent protein kinase PKR: structure and function. [Review]. J. Interf. Cytokine Res. 17, 503-524.
9. Cuevas, B. D., Lu, Y., Mao, M., Zhang, J., LaPushin, R., Siminovitch, K., and Mills, G. B. (2001). Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase. J. Biol. Chem. 276, 27455-27461.
10. Dever, T. E. (2002). Gene-specific regulation by general translation factors. Cell 108, 545-556.
11. Dey, M., Cao, C., Dar, A. C., Tamura, T., Ozato, K., Sicheri, F., and Dever, T. E. (2005). Mechanistic link between PKR dimerization, autophosphorylation, and eIF2alpha substrate recognition. Cell 122, 901-913.
12. Donze, O., Deng, J., Curran, J., Sladek, R., Picard, D., and Sonenberg, N. (2004). The protein kinase PKR: a molecular clock that sequentially activates survival and death programs. EMBO J. 23, 564-571.
13. Dorrello, N. V., Peschiaroli, A., Guardavaccaro, D., Colburn, N. H., Sherman, N. E., and Pagano, M. (2006). S6K1- and beta-TRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314, 467-471.
14. Downward, J. (2004). PI 3-kinase, Akt and cell survival. Semin. Cell Dev. Biol. 15, 177-182.
15. Durbin, R. K., Mertz, S. E., Koromilas, A. E., and Durbin, J. E. (2002). PKR protection against intranasal vesicular stomatitis virus infection is mouse strain dependent. Viral Immunol. 15, 41-51.
16. Engelman, J. A., Luo, J., and Cantley, L. C. (2006). The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7, 606-619.
17. Franke, T. F., Hornik, C. P., Segev, L., Shostak, G. A., and Sugimoto, C. (2003). PI3K/Akt and apoptosis: size matters. Oncogene 22, 8983-8998.
18. Georgescu, M. M., Kirsch, K. H., Akagi, T., Shishido, T., and Hanafusa, H. (1999). The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region. Proc. Natl. Acad. Sci. USA 96, 10182-10187.
19. Gingras, A. C., Gygi, S. P., Raught, B., Polakiewicz, R. D., Abraham, R. T., Hoekstra, M. F., Aebersold, R., and Sonenberg, N. (1999a). Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev. 13, 1422-1437.
20. Gingras, A. C., Raught, B., Gygi, S. P., Niedzwiecka, A., Miron, M., Burley, S. K., Polakiewicz, R. D., Wyslouch-Cieszynska, A., Aebersold, R., and Sonenberg, N. (2001a). Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev. 15, 2852-2864.
21. Gingras, A. C., Raught, B., and Sonenberg, N. (1999b). eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68, 913-963.
22. Gingras, A. C., Raught, B., and Sonenberg, N. (2001b). Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15, 807-826.
23. Gout, I., Middleton, G., Adu, J., Ninkina, N. N., Drobot, L. B., Filonenko, V., Matsuka, G., Davies, A. M., Waterheld, M., and Buchman, V. L. (2000). Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein. EMBO J. 19, 4015-4025.
24. Grolleau, A., Bowman, J., Pradet-Balade, B., Puravs, E., Hanash, S., Garcia-Sanz, J. A., and Beretta, L. (2002). Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics. J. Biol. Chem. 277, 22175-22184.
25. Gupta, S., Stuffrein, S., Plattner, R., Tencati, M., Gray, C., Whang, Y. E., and Stanbridge, E. J. (2001). Role of phosphoinositide 3-kinase in the aggressive tumor growth of HT1080 human fibrosarcoma cells. Mol. Cell. Biol. 21, 5846-5856.
26. Han, B., Dong, Z., Liu, Y., Chen, Q., Hashimoto, K., and Zhang, J. T. (2003). Regulation of constitutive expression of mouse PTEN by the 5′-untranslated region. Oncogene 22, 5325-5337.
27. Harding, H. P., Zhang, Y., Bertolotti, A., Zeng, H., and Ron, D. (2000). Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol. Cell 5, 897-904.
28. Hay, N. and Sonenberg, N. (2004). Upstream and downstream of mTOR. Genes Dev. 18, 1926-1945.
29. Hresko, R. C. and Mueckler, M. (2005). mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J. Biol. Chem. 280, 40406-40416.
30. Kaufman, R. J. (2000). Double-stranded RNA-activated protein kinase PKR. In: Translational Control of Gene Expression., ed. N. Sonenberg, J.W.B. Hershey, and M. B. Mathews, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 503-527.
31. Kazemi, S., Papadopoulou, S., Li, S., Su, Q., Wang, S., Yoshimura, A., Matlashewski, G., Dever, T. E., and Koromilas, A. E. (2004). Control of alpha subunit of eukaryotic translation initiation factor 2 (eIF2 alpha) phosphorylation by the human papillomavirus type 18 E6 oncoprotein: implications for eIF2 alpha-dependent gene expression and cell death. Mol. Cell. Biol. 24, 3415-3429.
32. Kimball, S. R. and Jefferson, L. S. (2000). Regulation of translation initiation in mammalian cells by amino acids. In: Translational Control of Gene Expression., ed. N. Sonenberg, J.W.B. Hershey, and M. B. Mathews, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 561-579.
33. Kumar, A., Yang, Y. L., Flati, V., Der, S., Kadereit, S., Deb, A., Haque, J., Reis, L., Weissmann, C., and Williams, B. R. (1997). Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J. 16, 406-416.
34. Lekmine, F., Sassano, A., Uddin, S., Smith, J., Majchrzak, B., Brachmann, S. M., Hay, N., Fish, E. N., and Platanias, L. C. (2004). Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein. Exp. Cell Res. 295, 173-182.
35. Lekmine, F., Uddin, S., Sassano, A., Parmar, S., Brachmann, S. M., Majchrzak, B., Sonenberg, N., Hay, N., Fish, E. N., and Platanias, L. C. (2003). Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons. J. Biol. Chem. 278, 27772-27780.
36. Mothe-Satney, I., Brunn, G. J., McMahon, L. P., Capaldo, C. T., Abraham, R. T., and Lawrence, J. C., Jr. (2000). Mammalian target of rapamycin-dependent phosphorylation of PHAS-I in four (S/T)P sites detected by phosphospecific antibodies. J. Biol. Chem. 275, 33836-33843.
37. Naga Prasad, S. V., Laporte, S. A., Chamberlain, D., Caron, M. G., Barak, L., and Rockman, H. A. (2002). Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex. J. Cell Biol. 158, 563-575.
38. Platanias, L. C. (2005). Mechanisms of type-I- and type-II-interferon- mediated signalling. Nat. Rev. Immunol. 5, 375-386.
39. Robert, F. et al. (2006). Initiation of protein synthesis by hepatitis C virus is refractory to reduced eIF2-GTP·Met-tRNAiMet ternary complex availability. Mol. Biol. Cell 17, 4632-4644.
40. Ron, D. and Harding, H. P. (2000). PERK and translational control by stress in the endoplasmic reticulum. In: Translational Control of Gene Expression, ed. N. Sonenberg, J.W.B. Hershey, and M. B. Mathews, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 547-560.
41. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 60-74.
42. Sarbassov, D. D., Guertin, D. A., Ali, S. M., and Sabatini, D. M. (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101.
43. Scheid, M. P. and Woodgett, J. R. (2003). Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Lett. 546, 108-112.
44. Scheuner, D., Song, B., McEwen, E., Liu, C., Laybutt, R., Gillespie, P., Saunders, T., Bonner-Weir, S., and Kaufman, R. J. (2001). Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol. Cell 7, 1165-1176.
45. Schmidt, M. H., Chen, B., Randazzo, L. M., and Bogler, O. (2003). SETA/CIN85/Ruk and its binding partner AIP1 associate with diverse cytoskeletal elements, including FAKs, and modulate cell adhesion. J. Cell Sci. 116, 2845-2855.
46. Schroder, M. and Kaufman, R. J. (2005). The mammalian unfolded protein response. Annu. Rev. Biochem. 74, 739-789.
47. Sen, G. C. and Sarkar, S. N. (2005). Transcriptional signaling by double-stranded RNA: role of TLR3. Cytokine Growth Factor Rev. 16, 1-14.
48. Shahbazian, D., Roux, P. P., Mieulet, V., Cohen, M. S., Raught, B., Taunton, J., Hershey, J. W., Blenis, J., Pende, M., and Sonenberg, N. (2006). The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J. 25, 2781-2791.
49. Su, Q., Wang, S., Baltzis, D., Qu, L. K., Wong, A. H., and Koromilas, A. E. (2006). Tyrosine phosphorylation acts as a molecular switch to full-scale activation of the eIF2{alpha} RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 103, 63-68.
50. Ung, T. L., Cao, C., Lu, J., Ozato, K., and Dever, T. E. (2001). Heterologous dimerization domains functionally substitute for the double-stranded RNA binding domains of the kinase PKR. EMBO J. 20, 3728-3737.
51. Verdier, F., Valovka, T., Zhyvoloup, A., Drobot, L. B., Buchman, V., Waterfield, M., and Gout, I. (2002). Ruk is ubiquitinated but not degraded by the proteasome. Eur. J. Biochem. 269, 3402-3408.
52. Vivanco, I. and Sawyers, C. L. (2002). The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2, 489-501.
53. Wang, S., Raven, J. F., Baltzis, D., Kazemi, S., Brunet, D. V., Hatzoglou, M., Tremblay, M. L., and Koromilas, A. E. (2006). The catalytic activity of the eukaryotic initiation factor-2alpha kinase PKR is required to negatively regulate Stat1 and Stat3 via activation of the T-cell protein-tyrosine phosphatase. J. Biol. Chem. 281, 9439-9449.
54. Wang, X., Beugnet, A., Murakami, M., Yamanaka, S., and Proud, C. G. (2005). Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins. Mol. Cell. Biol. 25, 2558-2572.
55. Wong, A. H., Durbin, J. E., Li, S., Dever, T. E., Decker, T., and Koromilas, A. E. (2001). Enhanced antiviral and antiproliferative properties of a STAT1 mutant unable to interact with the protein kinase PKR. J. Biol. Chem. 276, 13727-13737.
56. Wong, A. H., Tam, N. W., Yang, Y. L., Cuddihy, A. R., Li, S., Kirchhoff, S., Hauser, H., Decker, T., and Koromilas, A. E. (1997). Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J. 16, 1291-1304.